Satoshi Obika

USPTO Granted Patents = 30 (Patent Applications = 14)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 1,528(Granted Patents)

Location History:

Takatsuki, JP (2008)
Minoo, JP (2021)
Osaka, JP (2001 - 2024)
Suita, JP (2014 - 2024)
Ibaraki, JP (2024)

Company Filing History:

Tokyo Medical and Dental University

patents

4 out of 21

National Institutes of Biomedical Innovation, Health and Nutrition

National Cerebral and Cardiovascular Center

patents

6. 2 out of 257

Mitsubishi Tanabe Pharma Corporation

patents

7. 1 out of 613

Sankyo Company, Limited

patents

8. 1 out of 2

Tokyo University of Science Education Foundation Administrative Organization

patents

9. 1 out of 1

Luxna Biotech Co., Ltd.

Aichi Medical University

13. 3 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398171 - 5'-modified nucleoside and nucleotide using same (2025-08-26),

2. 12344841 - Chimeric double-stranded nucleic acid (2025-07-01),

3. 12338265 - Crosslinked artificial nucleic acid ALNA (2025-06-24),

4. 12104154 - Antisense oligonucleic acid (2024-10-01),

5. 12071624 - Antisense oligonucleotide targeting ARL4C molecule, and nucleic acid drug using antisense oligonucleotide (2024-08-27),

6. 11905308 - Nucleic acid compound and oligonucleotide (2024-02-20),

7. 11866705 - Small cell lung cancer therapeutic agent containing oligonucleotide (2024-01-09),

8. 11479773 - Antisense nucleic acid for inhibiting biosynthesis of chondroitin sulfate (2022-10-25),

9. 11286275 - Nucleic acid compound and oligonucleotide (2022-03-29),

10. 11273222 - Antisense nucleic acid targeting PCSK9 (2022-03-15),

11. 11261440 - Antisense oligonucleic acid (2022-03-01),

12. 11234995 - α-synuclein expression inhibitor (2022-02-01),

13. 11034955 - Chimeric double-stranded nucleic acid (2021-06-15),

14. 10961269 - Bridged nucleic acid GuNA, method for producing same, and intermediate compound (2021-03-30),

15. 10377789 - Oligonucleotide and artificial nucleoside having guanidine bridge (2019-08-13),

Title: The Innovative Journey of Satoshi Obika

Introduction: Satoshi Obika, a pioneering inventor hailing from Osaka, Japan, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Satoshi Obika's most recent patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we perceive transportation and safety on the roads.

Career Highlights: With a career spanning over two decades, Obika has been at the forefront of technological advancements, holding key positions in leading research institutions and collaborating with top-tier companies to bring his inventions to life.

Collaborations: Satoshi Obika has collaborated with renowned universities and tech giants to further his research and bring his ideas to fruition. His partnerships have led to the development of cutting-edge technologies that have reshaped industries.

Conclusion: Satoshi Obika's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazing inventor in the global landscape of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.